Alzprotect
Pierre Besançon, previously a Professor in Pharmacy, is the successor to former Laboratoires Delagrange. He is an experienced private investor in the field of biotech companies both in Europe and in the United States.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Alzprotect
It is a biopharmaceutical company which develop new bioactive molecules for the treatment of neurodegenerative diseases.